D 620

Known as: D-620 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2003
01219862003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Endothelium is a metabolically active secretory tissue and an important barrier for metabolic products. Little is known about its… (More)
Is this relevant?
2003
2003
Multidrug resistance in cancer chemotherapy frequently correlates with overexpression of the P-glycoprotein drug transporter… (More)
Is this relevant?
2000
2000
A rapid and highly sensitive method for the determination of verapamil [2,8-bis-(3,4-dimethoxyphenyl)-6-methyl-2-isopropyl-6… (More)
Is this relevant?
2000
2000
To determine the effect of age on exposure to the circulating major verapamil metabolites norverapamil, N-dealkylverapamil (D-617… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
Verapamil is subject to extensive oxidative metabolism mediated by cytochrome P450 enzymes with less than 5% of an oral dose… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
1999
1999
AIMS The present study was conducted to evaluate metabolism of the enantiomers of verapamil and norverapamil using a broad range… (More)
Is this relevant?
1990
1990
The pharmacokinetics, metabolism and pharmacodynamics of verapamil (160 mg p.o. of a pseudoracemic mixture) were evaluated in six… (More)
Is this relevant?
1988
1988
Cerebrospinal fluid (CSF) and plasma levels of verapamil and its two metabolites, norverapamil and D-620, were measured in seven… (More)
Is this relevant?
1988
1988
Pharmacokinetics of verapamil (VP) and its main N-dealkylated metabolites (nor-VP, D-617 and D-620) was studied in 10 patients… (More)
Is this relevant?
1986
1986
Pharmacokinetics of verapamil and of its three primary metabolites [norverapamil, 2-(3,4-dimethoxyphenyl)-2-isopropyl-6… (More)
Is this relevant?